PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2003 June; 4(2): 14–21.
Published online 2003 February 3. doi:  10.1208/pt040213
PMCID: PMC2750589

Poly(D,L-Lactide-Co-Glycolide) microspheres containing 5-fluorouracil: Optimization of process parameters

Abstract

The objective of this research was to optimize the processing parameters for poly(D,L-lactide-coglycolide) (PLGA) microspheres of 5-fluorouracil (5-FU) and to mathematically relate the process parameters and properties of microspheres. Microspheres were prepared by a water-in-oil-in-water emulsion solvent evaporation technique. A 32 factorial design was employed to study the effect of the volume of the internal phase of the primary emulsion and the volume of the external phase of the secondary emulsion on yield, particle size, and encapsulation efficiency of microspheres. An increase in the volume of the internal phase of the primary emulsion resulted in a decrease in yield and encapsulation efficiency and an increase in particle size of microspheres. When the volume of the external phase of the secondary emulsion was increased, a decrease in yield, particle size, and encapsulation efficiency was observed. Microspheres with good batch-to-batch reproducibility could be produced. Scanning electron microscopic study indicated that microspheres existed as aggregates.

Keywords: 5-fluorouracil, microspheres, PLGA microspheres, optimization

Full Text

The Full Text of this article is available as a PDF (499K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Rolland A, Wagner N, Chatelus A, Shrout B, Schaefer H. Site specific delivery to pilosebaceous structures using polymeric microspheres. Pharm Res. 1993;10:1738–1774. doi: 10.1023/A:1018922114398. [PubMed] [Cross Ref]
2. Maze GI, Reinhart RA, Agrawal RK, et al. Response to intracervicular controlled delivery of 25% tetracycline from poly(lactide/glycolide) film strips in SPT patients. J Clin Periodontol. 1995;22:860–867. doi: 10.1111/j.1600-051X.1995.tb01785.x. [PubMed] [Cross Ref]
3. Calabresi P, Chabner BA. Chemotherapy of neoplastic diseases. In: Hardman JG, Limbird LE, editors. Goodman and Gillmans The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: Pergamon Press; 1996. pp. 1225–1232.
4. Ogawa Y, Yamamoto M, Okada H, Yashiki T, Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microparticles of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull. 1988;36:1095–1103. [PubMed]
5. Conway BR, Oya AH. Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: effect of emulsifiers on microsphere characteristics and release kinetics. Eur J Pharm Biopharm. 1996;42(1):42–48.
6. Sato T, Kanke M, Schroeder HG, DeLuca PP. Porous biodegradable microspheres for controlled drug delivery, I: assessment of processing conditions and solvent removal techniques. Pharm Res. 1988;5:21–30. doi: 10.1023/A:1015855210319. [PubMed] [Cross Ref]
7. Jeyanthi R, Thanoo BC, Mehta RC, DeLuca PP. Effect of solvent removal technique on the matric characteristics of polylactide/glycolide microspheres for peptide delivery. J Control Release. 1996;38:235–244. doi: 10.1016/0168-3659(95)00125-5. [Cross Ref]
8. Jeyanthi R, Mehta RC, Thanoo BC, DeLuca PP. Effect of processing parameters on the properties of peptide containing PLGA microspheres. J Microencaps. 1997;14:163–174. doi: 10.3109/02652049709015330. [PubMed] [Cross Ref]
9. Li W-I, Anderson KW, DeLuca PP. Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method. J Control Release. 1995;37:187–198. doi: 10.1016/0168-3659(95)00077-1. [Cross Ref]
10. Li W-I, Anderson KW, Mehta RC, DeLuca PP. Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method. J Control Release. 1995;37:199–214. doi: 10.1016/0168-3659(95)00076-3. [Cross Ref]
11. Leo E, Pecquet S, Rojas J, Couvruer P, Fattal E. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by w/o/w solvent evaporation method. J Microencaps. 1998;15:421–430. doi: 10.3109/02652049809006869. [PubMed] [Cross Ref]
12. Crotts G, Gwan Park T. Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencaps. 1998;15:699–713. doi: 10.3109/02652049809008253. [PubMed] [Cross Ref]
13. Schlicher JAM, Postma NS, Zuidema J, Talsma H, Hennik WE. Preparation and characterization of poly (D, L-lactic-co-glycolic acid) microspheres containing desferrixamine. Int J Pharm. 1997;153(2):235–245. doi: 10.1016/S0378-5173(97)00116-6. [Cross Ref]
14. Jeffery H, Davis SS, O Hagan DT. Preparation and characterization of poly(lactide-co-glycolide) microparticles, II: entrapment of a model protein using a (water in oil) in water emulsion solvent evaporation technique. Pharm Res. 1993;10(3):362–368. doi: 10.1023/A:1018980020506. [PubMed] [Cross Ref]
15. Castellanos IJ, Carrasquillo KG, Jésus-Lopez J, Alvarez M, Griebenow K. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-inwater technique. J Pharm Pharmacol. 2001;53:167–178. doi: 10.1211/0022357011775361. [PubMed] [Cross Ref]
16. Yeh MK, Tung SM, Lu DW, Chiang CH. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. J Microencaps. 2001;18:507–519. doi: 10.1080/02652040010018100. [PubMed] [Cross Ref]
17. Schügers C, Larucelle N, Wihant N, Grandfils CH. Effect of emulsion stability on the morphology and porosity of semicrystalline poly-1-lactide microparticles prepared by W/O/W double emulsion evaporation. J Control Release. 1994;32:161–176. doi: 10.1016/0168-3659(94)90055-8. [Cross Ref]
18. Alex R, Bodmeier R. Encapsulation of water soluble drugs by a modified solvent evaporation method, I: effect of process and formulation variables on the drug entrapment. J Microencaps. 1990;7:347–355. doi: 10.3109/02652049009021845. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists